NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.

Saved in:
Bibliographic Details
Title: NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.
Authors: Xie M; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Vesuna F; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Botlagunta M; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Bol GM; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Pathology, University Medical Center Utrecht Cancer Center, GA, Utrecht, The Netherlands., Irving A; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Bergman Y; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Hosmane RS; Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, MD, USA., Kato Y; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Winnard PT Jr; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Raman V; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Pathology, University Medical Center Utrecht Cancer Center, GA, Utrecht, The Netherlands.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Source: Oncotarget [Oncotarget] 2015 Oct 06; Vol. 6 (30), pp. 29901-13.
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.4898